<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00148187</url>
  </required_header>
  <id_info>
    <org_study_id>0202M17442</org_study_id>
    <secondary_id>2P01DK013083-40A1</secondary_id>
    <nct_id>NCT00148187</nct_id>
  </id_info>
  <brief_title>Prediction of Medication Compliance Following Renal Transplantation</brief_title>
  <official_title>Prediction of Medication Compliance Following Renal Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to quantitate pre-transplant medication compliance, dialysis&#xD;
      compliance, and related psychological variables, and then examine their validity as&#xD;
      predictors of post-transplant noncompliant behaviors and clinically relevant outcomes (acute&#xD;
      rejection, graft loss, or death).&#xD;
&#xD;
      Hypothesis: Noncompliance with pre-transplant medication or with the dialysis prescription,&#xD;
      and specific psychological variables predict similarly noncompliant behaviors after&#xD;
      transplantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study is intended to provide preliminary data about the feasibility of recruiting&#xD;
      a cohort of subjects on hemodialysis and following them prospectively through the transplant&#xD;
      procedure. The study will document patient adherence to medications and treatment, both&#xD;
      before and after surgery. These preliminary data will permit appropriate design and power&#xD;
      calculations for a future study assessing our ability to predict post-transplant compliance,&#xD;
      based on pre-transplant behaviors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prediction of early medication adherence</measure>
    <time_frame>3 months</time_frame>
    <description>Prediction of declining medication adherence during first three months post kidney transplantation.</description>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Kidney Transplantation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pre-operative renal transplant recipients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult hemodialysis patients in renal transplant evaluation&#xD;
&#xD;
          -  Able to read test forms&#xD;
&#xD;
          -  Responsible for their own medications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a major risk of recurrent primary renal disease, e.g. hemolytic uremic&#xD;
             syndrome, oxalosis, membranoproliferative glomerulonephritis type II, focal segmental&#xD;
             glomerulosclerosis with nephrotic syndrome.&#xD;
&#xD;
          -  Patients with active psychosis&#xD;
&#xD;
          -  Patients who do not speak English.&#xD;
&#xD;
          -  Patients who live and will be followed outside the United States, except Canada.&#xD;
&#xD;
          -  Patients who are physically unable to open the Medication Event Monitoring System&#xD;
             (MEMS) cap.&#xD;
&#xD;
          -  Patients who are not responsible for taking their own medications, e.g. living in a&#xD;
             medical care facility.&#xD;
&#xD;
          -  Patients who are younger than 14 years old&#xD;
&#xD;
          -  Patients who will receive an extra renal organ (except pancreas), either&#xD;
             simultaneously or previously.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas E Nevins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>September 2, 2005</study_first_submitted>
  <study_first_submitted_qc>September 2, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2005</study_first_posted>
  <last_update_submitted>May 28, 2015</last_update_submitted>
  <last_update_submitted_qc>May 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medication adherence</keyword>
  <keyword>Patient compliance</keyword>
  <keyword>Kidney transplant</keyword>
  <keyword>Organ rejection</keyword>
  <keyword>Allograft loss</keyword>
  <keyword>Drug monitoring</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

